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Abstract
Background: Neurofibrillary tangles, mainly consisted of bundles of filaments formed by the microtubule-associated protein
Tau, are a hallmark of Alzheimer disease. Lead is a potent neurotoxin for human being especially for the developing
children, and Pb
2+ at high concentrations is found in the brains of patients with Alzheimer disease. However, it has not been
reported so far whether Pb
2+ plays a role in the pathology of Alzheimer disease through interaction with human Tau protein
and thereby mediates Tau filament formation. In this study, we have investigated the effect of Pb
2+ on fibril formation of
recombinant human Tau fragment Tau244–372 and its mutants at physiological pH.
Methodology/Principal Findings: As revealed by thioflavin T and 8-anilino-1-naphthalene sulfonic acid fluorescence, the
addition of 5–40 mMP b
2+ significantly accelerates the exposure of hydrophobic region and filament formation of wild-type
Tau244–372 on the investigated time scale. As evidenced by circular dichroism and Fourier transform infrared spectroscopy,
fibrils formed by wild-type Tau244–372 in the presence of 5–40 mMP b
2+ contain more b-sheet structure than the same
amount of fibrils formed by the protein in the absence of Pb
2+. However, unlike wild-type Tau244–372, the presence of 5–
40 mMP b
2+ has no obvious effects on fibrillization kinetics of single mutants H330A and H362A and double mutant H330A/
H362A, and fibrils formed by such mutants in the absence and in the presence of Pb
2+ contain similar amounts of b-sheet
structure. The results from isothermal titration calorimetry show that one Pb
2+ binds to one Tau monomer via interaction
with His-330 and His-362, with sub-micromolar affinity.
Conclusions/Significance: We demonstrate for the first time that the fibrillization of human Tau protein is accelerated by
exposure to lead via interaction with His-330 and His-362. Our results suggest the possible involvement of Pb
2+ in the
pathogenesis of Alzheimer disease and provide critical insights into the mechanism of lead toxicity.
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Introduction
Alzheimer disease, a progressive and irreversible neurodegen-
erative disease, is the leading dementia in the elderly population
(Approximately 10% of people over the age of 65) [1]. It has been
reported that more than 90% of Alzheimer disease cases are
sporadic despite several genetic mutations have been found in
Alzheimer disease patients [2,3]. Therefore, environmental
exposure may be an etiologic factor in the pathogenesis of
Alzheimer disease, either as triggers or as modulators of disease
progression [2]. Among them, lead (Pb), a potent neurotoxin for
human being, can be introduced into the organisms and may
potentially modulate Alzheimer disease pathology because of the
atmosphere emissions or the unhealthy workplaces especially in
developing countries [4]. Exposure to lead mainly has a variety of
adverse effects on the health of humans [4] especially for the
developing children [5] whose central nervous system is sensitive
and vulnerable to lead toxicity. Even exposure to low levels of
inorganic lead (Pb
2+) is known to induce lasting neurobehavioral
and cognitive impairments [4,5]. In addition, exposure to lead has
been reported to associate with amyotrophic lateral sclerosis [6].
Alzheimer disease is characterized by the presence of senile
plaques composed of amyloid b and neurofibrillary tangles.
Neurofibrillary tangles are mainly consisted of bundles of filaments
formed by the microtubule-associated protein Tau [7]. It has been
reported that exposure to lead can increase amyloid precursor
protein and amyloid b production in the aging brains of rodent [8]
and primate [9,10]. Meanwhile Pb
2+ at high concentrations has
been found in the brains of patients with Alzheimer disease [2] and
with diffuse neurofibrillary tangles with calcification [11].
However, it has not been reported so far whether Pb
2+ plays a
role in the pathology of Alzheimer disease through interaction
with human Tau protein and thereby mediates Tau filament
formation.
Tau binds to microtubules through repeat domain in their C-
terminal part [12]. Because the repeat domain of Tau forms the
core of paired helical filaments in Alzheimer disease and also
assembles more readily than full-length Tau into bona fide paired
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25020helical filaments in vitro [13,14], we employed recombinant human
Tau fragment Tau244–372 consisting of the four-repeat microtubule
binding domain for studying kinetics of Tau fibril formation. In
this study, we investigated the effect of Pb
2+ on fibril formation of
recombinant Tau244–372 and its mutants at physiological pH by
using several biophysical methods, such as thioflavin T (ThT)
binding, far-UV circular dichroism (CD), Fourier transform
infrared (FTIR) spectroscopy, transmission electron microscopy
(TEM), and isothermal titration calorimetry (ITC). We demon-
strated for the first time that the fibrillization of human Tau
protein was accelerated by exposure to 5–40 mMP b
2+ via
interaction with His-330 and His-362, with sub-micromolar
affinity. Our results suggest the possible involvement of Pb
2+ in
the pathogenesis of Alzheimer disease and provide important
insights into the mechanism of lead toxicity.
Materials and Methods
Materials
Heparin (average MW=6 kDa), ThT, and 8-anilino-1-naphtha-
lene -sulfonic acid (ANS) were obtained from Sigma-Aldrich (St.
Louis, MO). Dithiothreitol (DTT) was obtained from Ameresco
(Solon, OH). All other chemicals used including Pb(NO3)2 were
made in China and were of analytical grade.
Plasmids and proteins
The cDNA encoding human Tau fragment Tau244–372 was
amplified using the plasmid for human Tau40 (kindly provided by
Dr. Michel Goedert) as a template. The PCR-amplified Tau244–
372 was subcloned into pRK172 vector. Single histidine mutants
H330A and H362A and double mutant H330A/H362A of
Tau244–372 were generated using primers CACCTCCTGG-
TTTGGCATGGATGTT/AACATCCATGCCAAACCAGGA-
GGTG for H330A and GACAATATGCCCCACGTCCC/G-
GGACGTGGGGCATATTGTC for H362A. Triple mutant
H268A/H299A/H329A and histidine-less mutant H268A/
H299A/H329A/H330A/H362A were generated in a similar
manner. Recombinant Tau244–372 and its mutants were expressed
in Escherichia coli and purified to homogeneity by SP sepharose
chromatography as described [15,16]. Purified Tau protein was
analyzed by SDS-PAGE with one band and confirmed by mass
spectrometry. The concentration of human Tau fragment was
determined according to its absorbance at 214 nm with a standard
curve drawn by bovine serum albumin.
Thioflavin T binding assays
A 2.5 mM ThT stock solution was freshly prepared in 10 mM
HEPES buffer (pH 7.4) and passed through a 0.22-mm pore size
filter before use to remove insoluble particles. Under standard
conditions, 10 mM human Tau fragment was incubated in
10 mM HEPES buffer (pH 7.4) containing 100 mM NaCl,
1m MD T T ,a n d2 0mM ThT with or without Pb
2+ at 37uC
for up to 8 h in the presence of fibrillization inducer heparin used
in a Tau : heparin molar ratio of 4 : 1. The solutions with a
volume of 200 ml were placed into a well of a 96-well plate in
SpectraMax M2 microplate reader (Molecular Devices, Sunny-
vale, CA) using excitation at 440 nm and emission at 480 nm
with a wavelength cut-off at 475 nm [16]. Each sample was run
in triplicate or quadruplicate.
Kinetic model
Kinetic parameters were determined by fitting ThT fluores-
cence intensity versus time to the empirical Hill equation [17]:
F(t)~F(?)
(t=t50)
n
1z(t=t50)
n ð1Þ
where F(‘) is the fluorescence intensity in the long time limit, t50 is
the elapsed time at which F is equal to one-half of F(‘), and n is a
cooperativity parameter.
ANS binding assays
A 2.5 mM ANS stock solution was freshly prepared in 10 mM
HEPES buffer (pH 7.4) and passed through a 0.22-mm pore size
filter before use to remove insoluble particles. Under standard
conditions, 10 mM human Tau fragment was incubated in 10 mM
HEPES buffer (pH 7.4) containing 1 mM DTT and 20 mM ANS
with or without Pb
2+ at 37uC for up to 1 h in the presence of
heparin used in a Tau : heparin molar ratio of 4 : 1. The
fluorescence of ANS was excited at 350 nm with a slit-width of
5.0 nm and the emission was 470 nm with a slit-width of 7.5 nm
on an LS-55 luminescence spectrometer (PerkinElmer Life
Sciences, Shelton, CT). Assays in the absence of the protein were
performed to correct for unbound ANS emission fluorescence
intensities.
CD measurements
Under standard conditions, 10 mM human Tau fragment was
incubated in 30 mM NaH2PO4-Na2HPO4 buffer (pH 7.4) (or
50 mM sodium acetate buffer at pH 7.4) containing 1 mM DTT
and 2.5 mM heparin with or without Pb
2+ at 37uC for up to 1 h.
Circular dichroism spectra were obtained by using a Jasco J-810
spectropolarimeter (Jasco Corp., Tokyo, Japan) with a thermo-
stated cell holder. Quartz cell with a 1 mm light-path was used for
measurements in the far-UV region. Spectra were recorded from
195 to 250 nm for far-UV CD. The scan number for one sample
was 45, and the scan time for each scan was about 74 s. No time
interval was set between the sequential two scans. The final
concentration of Tau244–372 was kept at 10 mM. The spectra of all
scans were corrected relative to the buffer blank. The mean
residue molar ellipticity [h] (deg? cm
2?dmol
21) was calculated
using the formula [h]=(hobs/10)(MRW/lc), where hobs is the
observed ellipticity in deg, MRW the mean residue molecular
weight (106.1 Daltons for Tau fragment), l the path length in cm,
and c the protein concentration in g/ml.
Fourier transform infrared spectroscopy
FTIR spectra of human Tau fibril samples were recorded in
KBr pellets using a Nicolet 5700 FTIR spectrophotometer
(Thermo Electron, Madison, WI). 200 mM human Tau fragment
was incubated in 10 mM HEPES buffer (pH 7.4) containing
100 mM NaCl, 1 mM DTT, and 5 mM heparin with or without
Pb
2+ at 37uC for overnight. Then the samples were lyophilized
(freeze drying) at 240uC for FTIR measurements. FTIR spectra
were recorded in the range from 400 to 4000 cm
21 at 4 cm
21
resolution. The sample was scanned 128 times in each FTIR
measurement, and the spectrum acquired is the average of all
these scans. After FTIR assays, the spectra are analyzed by
OMNIC 8 software to obtain FTIR second derivative spectra.
Transmission electron microscopy
The formation of filaments by human Tau fragment was
confirmed by electron microscopy of negatively stained samples.
Sample aliquots of 10 ml were placed on copper grids, and left at
room temperature for 1–2 min, rinsed with H2O twice, and then
stained with 2% (w/v) uranyl acetate for another 1–2 min. The
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electron microscope (Hitachi, Tokyo, Japan) operating at 100 kV.
Isothermal titration calorimetry
ITC experiments on the interaction of Pb
2+ with Tau244–372 and
its mutants were carried out at 25.0uC using a VP-ITC titration
calorimetry (MicroCal, Northampton, MA). Freshly purified Tau
proteins (wild-type Tau244–372, single mutants H330A and H362A,
double mutant H330A/H362A, triple mutant H268A/H299A/
H329A, and histidine-less mutant H268A/H299A/H329A/
H330A/H362A) were dialyzed against 50 mM Bis-Tris buffer
(pH 7.4) containing 1 mM ethylenediaminetetraacetic acid
(EDTA) and 100 mM NaCl, overnight at 4uC and then dialyzed
against 50 mM Bis-Tris buffer (pH 7.4) containing 100 mM NaCl
extensively to remove EDTA. A solution of 100 mM Tau protein
was loaded into the sample cell (1.43 ml), and a solution of
1.5 mM Pb
2+ was placed in the injection syringe (280 ml). The first
injection (2 ml) was followed by 19–24 injections of 10 ml. Dilution
heats of Pb
2+ were measured by injecting Pb
2+ solution into buffer
alone and were subtracted from the experimental curves prior to
data analysis. The stirring rate was 300 rpm. The resulting data
were fitted to a single set of identical sites model using MicroCal
ORIGIN software supplied with the instrument, and the standard
molar enthalpy change for the binding, DbH0
m, the dissociation
constant, Kd, and the binding stoichiometry, n, were thus obtained.
The standard molar free energy change, DbG0
m, and the standard
molar entropy change, DbS0
m, for the binding reaction were
calculated by the fundamental equations of thermodynamics
[16,18]:
DbG0
m~RT lnKd ð2Þ
DbS0
m~ DbH0
m{DbG0
m
 
T ð3Þ
Results
The presence of Pb
2+ enhanced Tau aggregation
The enhanced fluorescence emission of the dye ThT, a specific
marker for the b-sheet conformation of fibril structures, has been
widely used for monitoring the kinetics of amyloid fibril formation
[16,17,19]. In order to mimic Tau fibrillization in vivo, heparin has
been often employed to induce Tau filament formation in vitro [16–
18,20]. The kinetics for heparin-mediated Tau filament formation
can be characterized by a lag period, followed by a period of
exponential growth and an asymptotic approach to equilibrium
[21].
In this paper, recombinant human Tau fragment Tau244–372
was incubated with Pb
2+ ranging from 5 to 40 mM. Fitting human
Tau fragment aggregation kinetic data (Fig. 1A) with the empirical
Hill equation gave t50 and F(‘) values which reflect the lag phase
and the final quantity of Tau244–372 amyloid formation respec-
tively. The corresponding kinetic parameters are summarized in
Table 1. As shown in Table 1, the value of t50 of Tau244–372
aggregation monitored by ThT binding assays were 143, 103, 142,
164, and 146 min in the presence of 5, 10, 20, 30, and 40 mM
Pb
2+ respectively, remarkably shorter than that in the absence of
Pb
2+ (255 min). The value of t50 reached the minimum at the
molar ratio of Pb
2+ to Tau of 1:1, and then got longer at larger
ratios of Pb
2+/Tau (from 2:1 to 4:1). Therefore, as revealed by
ThT binding assays (Fig. 1A and Table 1), the addition of 5–
40 mMP b
2+ significantly accelerated filament formation of wild-
type Tau244–372 on the investigated time scale, compared with no
Pb
2+. Our control experiments verified that Pb
2+ did not induce
Tau filament formation in the absence of heparin on the
investigated time scale of 8 h (Fig. S1).
Effect of Pb
2+ on filament formation of wild-type Tau244–372 was
further monitored via measurement of the time-dependent ANS
fluorescence (Fig. 1B). Changes in ANS fluorescence are frequently
used to detect the solvent-exposed hydrophobic clusters [17,22].
As revealed by ANS fluorescence (Fig. 1B), the addition of 10 mM
Pb
2+ significantly accelerated the exposure of hydrophobic region
and filament formation of wild-type Tau244–372 on the investigated
time scale, compared with no Pb
2+.
Effect of Pb
2+ on the secondary structures of Tau244–372
CD spectroscopy was used to detect the conformational
conversion of human Tau fragment during fibril formation in
the presence and absence of Pb
2+. Fig. 2A–C shows the far-UV
CD spectra of wild-type Tau244–372 incubated with 0–10 mMP b
2+
Figure 1. Pb
2+ enhances Tau244–372 fibrillization. (A) 10 mM
Tau244–372 was incubated with 0–40 mMP b
2+ (black: 0 mM, red: 5 mM,
blue: 10 mM, yellow: 20 mM, green: 30 mM, and magenta: 40 mM) in
10 mM HEPES buffer (pH 7.4) containing 100 mM NaCl, 1 mM DTT,
2.5 mM heparin, and 20 mM ThT, and ThT binding assays were carried
out at 37uC. Data are expressed as mean 6 S.D. (n=3–4). (B) 10 mM
Tau244–372 was incubated with 0–10 mMP b
2+ (black: 0 mM, and blue:
10 mM) in 10 mM HEPES buffer (pH 7.4) containing 1 mM DTT, 2.5 mM
heparin and 20 mM ANS, and ANS binding assays were carried out at
37uC.
doi:10.1371/journal.pone.0025020.g001
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beginning, the CD spectra measured for Tau244–372 in the absence
of Pb
2+ had a strong negative peak at 200 nm, indicative of a
largely random coil structure. With the increase of the incubation
time, the peak at 200 nm became smaller but the CD signal at
218 nm became larger gradually, indicative of b-sheet structure
formed. As shown in Fig. 2B and 2C, such two signals of CD
spectra of Tau244–372 in the presence of Pb
2+ (5 and 10 mM)
changed larger and faster than those in the absence of Pb
2+
(Fig. 2A). Fig. 2D shows the effect of Pb
2+ on the relative change in
the b-sheet content of Tau244–372 during fibril formation, studied
by monitoring the CD signal at 218 nm ([h]218). As shown in
Fig. 2D, in phosphate buffer, the value of [h]218 of Tau244–372
aggregation in the absence of Pb
2+ increased gradually from
22900 to 26100 deg?cm
2?dmol
21 when the incubation time
increased gradually from 0 to 54.4 min. In the presence of 10 mM
Pb
2+, however, the value of [h]218 of Tau244–372 aggregation
increased from 23200 to about 29000 deg?cm
2?dmol
21 in the
same incubation time range, reaching the maximum at 37.1 min.
Similar phenomena were observed in the presence of 20, 30, and
40 mMP b
2+ in phosphate buffer (Fig. 2D). The maximal
concentration of Pb
2+ in phosphate buffer should be about
11 mMa t2 0 uC and about 20 mMa t3 7 uC according to the
solubility product of PbHPO4. Consequently, it is not clear
whether the traces in Fig. 2D are affected by insufficient lead
solubility. We then performed CD measurements in sodium
acetate buffer, in which Pb(CH3COO)2 is soluble. As shown in
Fig. S2, in sodium acetate buffer, the value of [h]218 of Tau244–372
aggregation in the absence of Pb
2+ increased gradually from
24500 to 26300 deg?cm
2?dmol
21 when the incubation time
increased gradually from 0 to 36 min. In the presence of 10–
40 mMP b
2+, however, the value of [h]218 of Tau244–372
aggregation increased from 24300 to about 28000 deg?cm
2?
Table 1. Kinetic parameters for fibril formation of human Tau
fragment in the absence and in the presence of Pb
2+ as
determined by ThT binding assays at 37uC.
Molar ratio ( Pb
2+/Tau) t50 (min) F(‘)
02 5 5 633 3 1 65
1:2 143621 32164
1:1 103623 2 3 63
2:1 142632 8 0 65
3:1 164634 2 3 67
4:1 146632 7 6 64
Best-fit values of these kinetic parameters were derived from non-linear least
squares modeling of the empirical Hill equation to the data plotted in Fig. 1A.
Errors shown are standard errors of the mean.
doi:10.1371/journal.pone.0025020.t001
Figure 2. Far-UV CD spectra of Tau244–372 during fibril formation in the presence and absence of Pb
2+ at 376C. 10 mM Tau244–372 was
incubated with 0–10 mMP b
2+ (A: 0 mM, B: 5 mM, and C: 10 mM). The arrows represented the incubation time increased gradually from 0 (the top, blue)
to 54.4 min (the bottom, red). (D) Effect of Pb
2+ on the relative change in the b-sheet content of Tau244–372 during fibril formation, studied by
monitoring the CD signal at 218 nm. 10 mM Tau244–372 was incubated with 0–40 mMP b
2+ (black: 0 mM, red: 5 mM, blue: 10 mM, yellow: 20 mM, green:
30 mM, and magenta: 40 mM) in 30 mM phosphate buffer (pH 7.4) containing 1 mM DTT and 2.5 mM heparin.
doi:10.1371/journal.pone.0025020.g002
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21 in the same incubation time range, reaching the
maximum at 16 min. Therefore, as evidenced by CD spectroscopy
(Figs. 2D and S2), fibrils formed by wild-type Tau244–372 in the
presence of Pb
2+ contain more b-sheet structure than the same
amount of fibrils formed by the protein in the absence of Pb
2+, and
the addition of 5–40 mMP b
2+ significantly accelerated fibril
formation of wild-type Tau244–372 on the investigated time scale.
Clearly, the traces with molar ratios of Pb
2+/Tau from 1:1 to 4:1
in the same buffer were similar (Figs. 2D and S2) not because of
the same concentration of Pb
2+ in solution, but due to the fact that
one Pb
2+ bound to one Tau monomer with sub-micromolar
affinity (see below).
FTIR was used to confirm the change in b-sheet structure of
human Tau244–372 fibrils in the presence and absence of Pb
2+.
Fig. 3A shows the FTIR spectra in the amide I9 region of Tau244–
372 fibrils and Fig. 3B displays the second derivatives. The amide I9
band at 1630 cm
21 is characteristic for b-sheet formed by amyloid
fibrils [23]. As shown in Fig. 3B, compared with that in the
absence of Pb
2+, an increase of the band at 1630 cm
21 was clearly
observed for Tau244–372 fibrils in the presence of 20 mMP b
2+,
further supporting the conclusion reached by CD spectroscopy
that fibrils formed by wild-type Tau244–372 in the presence of Pb
2+
contain more b-sheet structure than the same amount of fibrils
formed by the protein in the absence of Pb
2+.
Characterization of morphology of human Tau samples
TEM was used to study the morphology of human Tau samples
incubated with 0–20 mMP b
2+. Our TEM studies confirmed the
formation of fibrils by wild-type Tau244–372. As shown in Fig. 4A
and 4B, long fibrils as well as short filaments were observed in both
samples, indicating that the addition of Pb
2+ had no significant
effect on the morphology of Tau samples.
His-330 and His-362 are key residues in the interaction of
Pb
2+ with Tau protein
To determine the reason for the enhancing effect of Pb
2+ on
Tau fibrillization, histidine mutants of Tau244–372 were employed.
There are five histidine residues in Tau244–372: His-268, His-299,
His-329, His-330, and His-362. In this study, Tau244–372 mutants
containing single, double, triple, and quintuple histidine mutations
Figure 3. FTIR spectra of Tau244–372 fibrils formed in the
presence and absence of Pb
2+ at 376C. (A) The FTIR spectra in the
amide I9 region of Tau244–372 fibrils. (B) The second derivatives of the
amide I9 bands of Tau244–372 fibrils. 200 mM Tau244–372 was incubated
with 0–20 mMP b
2+ (black: 0 mM, and red: 20 mM) in 10 mM HEPES
buffer (pH 7.4) containing 100 mM NaCl, 1 mM DTT, and 5 mM heparin,
to produce fibrils.
doi:10.1371/journal.pone.0025020.g003
Figure 4. Transmission electron micrographs of Tau244–372
samples after incubation in the presence and absence of Pb
2+.
10 mM Tau244–372 was incubated with 0–20 mMP b
2+ (A: 0 mM, and B:
20 mM) at 37uC for 8 h, in 10 mM HEPES buffer (pH 7.4) containing
100 mM NaCl, 1 mM DTT, and 2.5 mM heparin. A 2% (w/v) uranyl
acetate solution was used to negatively stain the fibrils. The scale bars
represent 200 nm.
doi:10.1371/journal.pone.0025020.g004
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experiments using such mutants were performed in order to
provide information about the binding sites of Pb
2+ in Tau protein
and the role of histidine residues in Tau assembly. Fig. 5 shows the
effects of Pb
2+ on single mutants H330A and H362A and double
mutant H330A/H362A of Tau244–372. Unlike wild-type Tau244–
372, the presence of 5–40 mMP b
2+ had no obvious effects on
fibrillization kinetics of single mutants H330A (Fig. 5A) and
H362A (Fig. 5B) and double mutant H330A/H362A (Fig. 5C)
except that 10 mMP b
2+ accelerated the aggregation of H362A to
some extent (blue trace, Fig. 5B), and fibrils formed by such
mutants in the absence and in the presence of Pb
2+ contain similar
amounts of b-sheet structure (Fig. 5D). However, the addition of
5–40 mMP b
2+ significantly accelerated filament formation of
triple mutant H268A/H299A/H329A of Tau244–372 on the
investigated time scale (data not shown). The above results suggest
that His-330 and His-362 are key residues in the interaction of
Pb
2+ with Tau protein. It should be pointed out that the significant
intensity variations between different measurements in Fig. 5 could
reflect different fibril concentrations.
Thermodynamics of the binding of Pb
2+ to Tau protein
ITC provides a direct route to the complete thermodynamic
characterization of non-covalent, equilibrium interactions
[16,18,22], and DTT concentrations as low as 1 mM can cause
severe baseline artifacts due to background oxidation during the
titration. Therefore ITC was used to measure the binding affinity
of Pb
2+ to Tau protein in the absence of DTT. ITC profiles for the
binding of Pb
2+ to wild-type Tau244–372 and its histidine mutants at
25.0uC are shown in Figs. 6 and S3. The top panels show
representatively raw ITC curves resulting from the injections of
Pb
2+ into a solution of wild-type Tau244–372 (Fig. 6A), single
mutants H362A (Fig. 6B) and H330A (Fig. S3A), double mutant
H330A/H362A (Fig. S3B), and triple mutant H268A/H299A/
H329A (Fig. 6C). The titration curves show that Pb
2+ binding to
wild-type Tau244–372 and its histidine mutants were exothermic,
Figure 5. His-330 and His-362 are key residues in the interaction of Pb
2+ with Tau244–372. 10 mM single mutants H330A (A) and H362A (B)
or double mutant H330A/H362A (C) of Tau244–372 were incubated with 0–40 mMP b
2+ (black: 0 mM, red: 5 mM, blue: 10 mM, yellow: 20 mM, green:
30 mM, and magenta: 40 mM) in 10 mM HEPES buffer (pH 7.4) containing 100 mM NaCl, 1 mM DTT, 2.5 mM heparin, and 20 mM ThT, and ThT binding
assays were carried out at 37uC. Data are expressed as mean 6 S.D. (n=3–4). (D) Effect of Pb
2+ on the relative change in the b-sheet content of single
mutants H330A (square) and H362A (circle) or double mutant H330A/H362A (triangle) during fibril formation, studied by monitoring the CD signal at
218 nm. 10 mM Tau244–372 was incubated with 0–10 mMP b
2+ (black: 0 mM, and blue: 10 mM) in 30 mM phosphate buffer (pH 7.4) containing 1 mM
DTT and 2.5 mM heparin.
doi:10.1371/journal.pone.0025020.g005
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bottom panels show the plots of the heat evolved per mole of Pb
2+
added, corrected for the heat of Pb
2+ dilution, against the molar
ratio of Pb
2+ to wild-type Tau244–372 (Fig. 6D), H362A (Fig. 6E),
H330A (Fig. S3C), H330A/H362A (Fig. S3D), and H268A/
H299A/H329A (Fig. 6F). The calorimetric data were best fit to a
model assuming a single set of identical sites. The thermodynamic
parameters for the binding of Pb
2+ to Tau244–372 are summarized
in Table 2. As shown in Table 2, one Pb
2+ bound to one wild-type
Tau244–372 (or one triple mutant H268A/H299A/H329A) mole-
cule with a dissociation constant of 0.217 mM (or 0.286 mM). The
binding affinity of Pb
2+ to single histidine mutant H362A was
significantly lower than that of wild-type Tau244–372, with a
dissociation constant of 0.546 mM, and a weak binding reaction
for Pb
2+ with single histidine mutant H330A was observed. No
binding reaction for Pb
2+ with double histidine mutant H330A/
H362A or histidine-less mutant was detected by ITC (Table 2),
demonstrating that His-330 and His-362 are key residues in the
interaction of Pb
2+ with Tau protein. Our ITC data (Table 2)
clearly indicated that at physiological pH, one Pb
2+ bound to one
Tau monomer via interaction with His-330 and His-362, with sub-
micromolar affinity.
Figure 6. ITC profiles for the binding of Pb
2+ to wild-type Tau244–372 and its mutants at 25.06C. The top panels represent the raw data for
sequential 10-ml injections of 1.5 mM Pb
2+ into 150 mM wild-type Tau244–372 (A), 150 mM single mutant H362A (B), and 150 mM triple mutant H268A/
H299A/H329A (C) in 50 mM Bis-Tris buffer (pH 7.4), respectively. The bottom panels (D, E, and F) show the plots of the heat evolved (kcal) per mole of
Pb
2+ added, corrected for the heat of Pb
2+ dilution, against the molar ratio of Pb
2+ to Tau244–372. The data (solid squares) were best fitted to a single
set of identical sites model and the solid lines represented the best fit.
doi:10.1371/journal.pone.0025020.g006
Table 2. Thermodynamic parameters for the binding of Pb
2+ to Tau244–372 (or full-length Tau protein) as determined by ITC at
25.0uC.
Tau244–372 Kd (mM) n DbH0
m (kcal mol
21) DbG0
m (kcal mol
21) DbS0
m (cal mol
21 K
21)
WT 0.21760.029 1.09060.003 26.7860.04 29.0860.08 7.7360.39
H330A 82648 0.5960.32 20.3160.21 25.7960.36 17.761.8
H362A 0.54660.020 0.16560.047 27.8560.29 28.5360.22 2.3261.72
DM NB – – – –
TM 0.28660.042 1.13060.005 26.1960.05 28.9260.08 9.1760.45
Histidine-less NB – – – –
Full-length Tau 0.2960.16 2.7260.06 27.8660.30 28.9160.32 3.5562.05
Thermodynamic parameters, Kd, DbH0
m, and n, were determined using a single set of identical sites model. The standard molar binding free energy (DbG0
m) and the
standard molar binding entropy (DbS0
m) for the binding reaction were calculated using Equations 2 and 3 respectively.
The buffer used was 50 mM Bis-Tris buffer (pH 7.4). Errors shown are standard errors of the mean.
WT, wild-type Tau244–372; DM, double mutant H330A/H362A of Tau244–372; TM, triple mutant H268A/H299A/H329A of Tau244–372; Histidine-less, histidine-less mutant
H268A/H299A/H329A/H330A/H362A.
NB, no binding observed in the present conditions.
doi:10.1371/journal.pone.0025020.t002
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Because heavy metals persist in the environment (they cannot be
destroyed biologically) and are carcinogenic to human being,
pollution by heavy metals poses a great potential threat to the
environment and human health [24,25]. Among them, lead is a
potent neurotoxin for human being especially for the developing
children due to a causal link between low-level chronic exposure to
lead and deficiencies in intelligence quotients in children [26–28].
The source of lead used in our daily life contains mining and
smelting of metalliferous ores, burning of leaded gasoline,
municipal sewage, industrial wastes, paints, and some food
[25,29,30]. Some early studies have indicated that exposure to
lead in early life could have long-term effects and thereby
significantly increases the risk of developing Alzheimer disease in
later years [31–33]. Recent studies in rodents have shown that
exposure to lead during brain development is able to predetermine
the expression and regulation of amyloid precursor protein and its
amyloid b product in old age [8,34]. It has been reported that
exposure to lead disturbs the balance between amyloid b
production and elimination [35]. Furthermore, the expression of
Alzheimer disease-related genes and their transcriptional regulator
are elevated in 23-year-old monkeys exposed to lead as infants
leading to an Alzheimer disease-like pathology in the aged
monkeys [10]. Chronic lead exposure also affects granule cell
morphology in lead-exposed rats, whose dendrites frequently
appear dystrophic, similar to those present in Alzheimer disease
[36]. Because Pb
2+ at high concentrations has been found in the
brains of patients with Alzheimer disease [2] and with diffuse
neurofibrillary tangles with calcification [11], we wanted to know
whether Pb
2+ plays a role in the pathology of Alzheimer disease
through enhancing Tau filament formation.
In this paper the concentration of Pb
2+ used was 5–40 mM
because of the following reasons. Firstly, it has been demonstrated
that there is no significant cytotoxicity to SH-SY5Y cells for 1–
50 mMo fP b
2+ at either 48 or 72 h [35]. Secondly, the
concentration of Pb
2+ we used is one order of magnitude higher
than that considered as lead poisoning by public health authorities
in the United States and France [37]. In addition, the
concentration of Tau protein we used is of the same order of
magnitude as that of endogenous Tau present in human brain
[38]. We demonstrated for the first time that the fibrillization of
human Tau protein was accelerated by exposure to 5–40 mMP b
2+
via interaction with His-330 and His-362, with sub-micromolar
affinity. In other words, His-330 and His-362 are key residues in
the interaction of Pb
2+ with Tau protein. Moreover, fibrils formed
by human Tau protein in the presence of 5–40 mMP b
2+
contained more b-sheet structure than the same amount of fibrils
formed by the protein in the absence of Pb
2+. In other words,
exposure to 5–40 mMP b
2+ enhanced the conversion of random
coil structure into b-sheet structure and thereby accelerated the
fibrillization of human Tau protein. Our results suggest the
possible involvement of Pb
2+ in the pathogenesis of Alzheimer
disease and provide critical insights into the mechanism of lead
toxicity.
For ITC experiments Tau244–372 was dialyzed overnight at 4uC
in the absence of DTT. It has been reported that similar
conditions (Tau244–394 is dialyzed for 7 days at 20uC in the absence
of DTT) result in the oxidation of the two cysteines and lead to the
formation of compact monomers and a minor population of
dimers [39]. Consequently, it is not clear which Tau species is
analyzed in the ITC measurements. We then turned to native gel
electrophoresis. As shown in Fig. S4, we observed only one
population of monomers, the extended Tau244–372 monomers, but
neither dimers nor compact monomers, in the ITC experimental
conditions. Lane 2 serves as a standard where Tau244–372 was in
the presence of DTT, resulting in a purely monomeric population
(Fig. S4). Clearly, the extended Tau244–372 monomers were
analyzed in our ITC measurements.
The above experiments were conducted using Tau244–372 with
four repeats, but filaments in Alzheimer disease contain full-length
Tau protein. There are ten histidine residues in full-length human
Tau protein and five histidine residues in Tau244–372. Our
additional ITC experiments (Fig. S5) indicated that in the absence
of DTT, Pb
2+ bound to full-length human Tau protein with a sub-
micromolar affinity (0.2960.16 mM) similar to Tau244–372, but
with a binding stoichiometry (2.7260.06) remarkably larger than
Tau244–372 (Table 2). Therefore, it is possible that other histidine
residues (or other residues) beyond the region can bind to Pb
2+ as
well.
In conclusion we have shown that: (i) the addition of
micromolar concentrations of Pb
2+ significantly accelerates the
exposure of hydrophobic region and filament formation of human
Tau protein; (ii) fibrils formed by human Tau protein in the
presence of micromolar concentrations of Pb
2+ contain more b-
sheet structure than the same amount of fibrils formed by the
protein in the absence of Pb
2+; (iii) the fibrillization of human Tau
protein is promoted by exposure to Pb
2+ via interaction with His-
330 and His-362, with sub-micromolar affinity. Information
obtained here can enhance our understanding of how low levels
of inorganic lead interact with microtubule-associated protein Tau
in pathological environments and thereby play a role in the
pathology of Alzheimer disease.
Supporting Information
Figure S1 Pb
2+ alone did not induce Tau filament
formation. 10 mM Tau244–372 was incubated with 0–10 mM
Pb
2+ (black: 0 mM, and blue: 10 mM) in 10 mM HEPES buffer
(pH 7.4) containing 100 mM NaCl, 1 mM DTT, 2.5 mM heparin,
and 20 mM ThT, or incubated with 10 mMP b
2+ (red) in 10 mM
HEPES buffer (pH 7.4) containing 100 mM NaCl, 1 mM DTT,
and 20 mM ThT. ThT binding assays were carried out at 37uC,
and all experiments were repeated at least twice.
(DOC)
Figure S2 Effect of Pb
2+ on the relative change in the b-
sheet content of Tau244–372 during fibril formation at
376C, studied by monitoring the CD signal at 218 nm.
10 mM Tau244–372 was incubated with 0–40 mMP b
2+ (black:
0 mM, red: 5 mM, blue: 10 mM, yellow: 20 mM, green: 30 mM, and
magenta: 40 mM) in 50 mM sodium acetate buffer (pH 7.4)
containing 1 mM DTT and 2.5 mM heparin.
(DOC)
Figure S3 ITC profiles for the binding of Pb
2+to Tau244–372
mutants at 25.06C. The top panels represent the raw data for
sequential 10-ml injections of 1.5 mM Pb
2+ into 150 mM single
mutant H330A (A) and 150 mM double mutant H330A/H362A
(B) in 50 mM Bis-Tris buffer (pH 7.4), respectively. The bottom
panels (C and D) show the plots of the heat evolved (kcal) per mole
of Pb
2+ added, corrected for the heat of Pb
2+ dilution, against the
molar ratio of Pb
2+ to Tau244–372. The data (solid squares) were
best fitted to a single set of identical sites model and the solid lines
represented the best fit.
(DOC)
Figure S4 Native gel electrophoresis of Tau244–372. Lane
1, Tau244–372 in the absence of DTT (oxidative conditions). Lane
2, Tau244–372 in the presence of 1 mM DTT (reducing conditions).
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monomer (M), was visible in lanes 1 and 2. Freshly purified wild-
type Tau244–372 was dialyzed against 50 mM Bis-Tris buffer
(pH 7.4) containing 1 mM EDTA and 100 mM NaCl, overnight
at 4uC and then dialyzed against 50 mM Bis-Tris buffer (pH 7.4)
containing 100 mM NaCl extensively to remove EDTA. The
samples were mixed with 26loading buffer and separated by 15%
native PAGE. Gel was stained by Coomassie Blue G250.
(DOC)
Figure S5 ITC profiles for the binding of Pb
2+ to full-
length Tau protein at 25.06C. The panel A represents typical
calorimetric titration of full-length Tau (150 mM) with Pb
2+
(1.0 mM) in 50 mM Bis-Tris buffer (pH 7.4). The first injection
(5 ml) was followed by 19 injections of 10 ml. The panel B shows
the plots of the heat evolved (kcal) per mole of Pb
2+ added,
corrected for the heat of Pb
2+ dilution, against the molar ratio of
Pb
2+ to full-length Tau. The data (solid squares) were best fitted to
a single set of identical sites model and the solid lines represented
the best fit.
(DOC)
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